CCL2 and metabolic dysfunction-associated steatotic liver disease: In the group of NAFLD patients, elevated serum MCP-1 levels were found in 78% (31/40) of cases, and a mean value of 189.0 ± 114.70 pg/mL was recorded, with a significant statistical difference compared to the group of PBC patients, at p < 0.001.